|
KMID : 1100620210080030160
|
|
Clinical and Experimental Emergency Medicine
2021 Volume.8 No. 3 p.160 ~ p.172
|
|
|
Recent update on the management of anaphylaxis
|
|
Quoc Quang Luu
Bich Tra Cao Thi
Jang Jae-Hyuk
Park Hae-Sim
|
|
|
Abstract
|
|
|
|
Anaphylaxis is a life-threatening systemic allergic reaction presenting various clinical manifestations. Its prevalence has increased in almost all age groups and both sexes. Food, venom, and drugs are major causes in both children and adults; a higher prevalence of food-induced anaphylaxis is noted in children, while a higher prevalence of drug-induced anaphylaxis is noted in adults. The pathogenic mechanism is mediated by immunologic and nonimmunologic mechanisms, where mast cells and basophils are key cells that release mediators. A diagnosis of anaphylaxis is mainly based on clinical symptoms and physical findings; however, an increased serum tryptase level is a useful biomarker. Epinephrine is the first-line drug to treat acute symptoms, and an epinephrine auto-injector should be prescribed for each patient. Antihistamines and systemic corticosteroids are used to relieve symptoms. This review updates current issues in the management of anaphylaxis as well as the new guidelines for proper diagnosis and treatment.
|
|
|
KEYWORD
|
|
|
Anaphylaxis, Biomarkers, Diagnosis, Epinephrine, Therapeutics
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|